The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...